Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SJP-0008 Phase III study in central retinal artery occlusion
jRCT2011230042Phase 3Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in central retinal artery occlusion (CRAO) comparing SJP-0008 with Placebo (2 arms). Primary endpoint: Efficacy. Started Feb 2024; status: completed.
02
Drugs
SJP-0008
03
Conditions
central retinal artery occlusion (CRAO)
Beyond the preview
Go deeper on jRCT2011230042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011230042.